Healthcare -
Biotechnology - NASDAQ - US
$ 8.5847
8.67 %
$ 425 M
Market Cap
-1.71
P/E
RGNX - GROSS PROFIT
Gross Profit RGNX - REGENXBIO Inc.
53 M
LAST VALUE
-64.40%
2 YEAR CAGR
-23.98%
5 YEAR CAGR
24.85%
10 YEAR CAGR